🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: Thiazolidinediones (TZDs) are insulin sensitizers that decreas...
Status
Unknown
Location
Taipei Veterans General Hospital, Taiwan
Start Date
2010-07
Trial ID
NCT01175486
Treatments Being Tested
In the treatment of type 2 diabetes (T2D), the number of patients requiring...
Status
Completed
Location
Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2019-08-05
Trial ID
NCT04013581
Treatments Being Tested
Thiazolidinediones (TZDs) are a commonly used antidiabetic drugs currently ...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2009-07
Trial ID
NCT00663143
Treatments Being Tested
This is a randomized, open-label, active-controlled, parallel, multicenter,...
Status
Recruiting
Location
The Catholic University of Korea, Seoul St. Mary's Hospital
Start Date
2025-06-11
Trial ID
NCT06972732
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-512148, adde...
Status
Completed
Location
Nea Clinic
Start Date
2006-10
Trial ID
NCT00357370
Treatments Being Tested
Treatment with thiazolidinediones (TZD) has recently been reported to possi...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01055223
Treatments Being Tested
It is well known that abnormal heart beats from the top parts of the heart,...
Status
Terminated
Location
Emory University Hospital
Start Date
2005-12
Trial ID
NCT00321204
Treatments Being Tested
The aim of this project is to identify subgroups of patients with type 2 di...
Status
Completed
Location
Exeter Clinical Research Facility
Start Date
2016-11-01
Trial ID
NCT02653209
Treatments Being Tested
The primary purpose of study is to estimate the incidence and comparative e...
Status
Completed
Location
Janssen Investigative Site
Start Date
2018-02-22
Trial ID
NCT03492580
This is a 24 week study comparing the efficacy of four dose levels of INT13...
Status
Completed
Location
Northern California Research
Start Date
2008-02
Trial ID
NCT00631007
Treatments Being Tested